Single Administration of Captopril and Combined Use with Beta-Blocker and/or Thiazide Diuretic in the Treatment of Essential Hypertension

Abstract

Thirty-four patients with essential hypertension at WHO stage I or II were divided into three groups. Group I consisted of 22 cases who displayed normal renin activity (NR) or low renin activity (LR) and who received a single adminis tration of captopril. Group II consisted of 6 cases given beta-blockers after ad ministration of captopril. Group III consisted of 6 cases in whom beta-blocker was replaced with thiazide diuretics after administration of captopril alone. Blood pressure decreased significantly by captopril treatment alone in group I of the NR and LR subgroups (except for the diastolic blood pressure [DBP] of the NR subgroup) and fell below the target blood pressure (SBP of 165 mmHg and DBP of 95 mmHg) in 86% of the NR subgroup and 73% of the LR subgroup. Com bined treatment with captopril and beta-blocker in Group II did not decrease blood pressure any lower than with captopril alone treatment and achieved the target blood pressure in only 50% of the patients. In group III, combined treat ment with catopril and thiazide achieved the target blood pressure in 100% of the patients. Plasma renin activity (PRA) was increased by captopril but reduced by captopril in combination with beta-blocker. However, when beta-blocker was replaced with thiazide, PRA increased. The serum sodium concentration was significantly reduced in the LR subgroup after a single administration of cap topril, but there was no other variation.

Get full access to this article

View all access options for this article.

References

Report of a WHO Expert Committee : Arterial Hypertension, World Health Organization Technical Report Series 628, Geneva: World Health Organization, 1978.

Atkinson AB , Robertson Jib : Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 2:836-389, 1979.

Heel RC , Brogden RN , Speight TM , et al: Captopril; a preliminary review of its pharmacological properties and therapeutic efficiency. Drugs 20:409-452, 1980.

Bravo EL Tarazi RC : Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1: 39-46, 1979.

Joint National Committee : On detection, evaluation and treatment of high blood pressure; the 1984 report . Arch Intern Med 44:1045-1057, 1984 .

Zanchetti A. : A re-examination of stepped care: A retrospective and a prospective. J Cardiiovasc Pharmacol 7 (Suppl 1):S126-S131, 1985.

Ondetti MA , Rubin B. , Cushman DW : Design of specific inhibitors of angiotensin converting enzyme: New class of orally active antihypertensive agents. Science 196:441-444, 1977.

Laragh JH : The renin system in high blood pressure, from disbelief to reality: Converting enzyme blockade for analysis and treatment. Prog Cardiovasc Dis 21:159-166, 1978.

Bravo EL , Tarazi RC : Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1:39-46, 1979.

10.

MacGregor GA , Markandu ND , Roulston JE , et al: Maintenance of blood pressure by the renin angiotensin system in normal man. Nature 291:329-331, 1981.

11.

Havelka Jri , Vetter H. , Studer A. , et al: Acute and chronic effects of the angiotensin converting enzyme inhibitor captopril in severe hypertension. Am J Cardiol 49:1467-1474, 1982.

12.

Case DB , Atlas SA , Marion RH , et al: Long-term efficacy of captopril in renovascular and essential hypertension. Am J Cardiol 49:1440-1446, 1982.

13.

Lijnen P. , Staessen J. , Fagard R. , et al: Increase in plasma aldosterone during prolonged captopril treatment . Am J Cardiol 49:1561-1563, 1982 .

14.

Stumpe KO , Overlack A. , Kollock R. , et al: Long-term effect of angiotensin-converting enzyme inhibitor with captopril in mild to moderate essential hypertension. Br J Clin Pharmacol 14:121A-126S, 1982.

15.

Staessen J. , Fagard R. , Lijnen P. , et al: Double-blind comparison between propranolol and bendroflumethiazide in captopril treated persistent hypertensive patients . Am Heart J 106:321-328, 1983.

16.

Leonetti G. , Biachini C. , Terzoli L. , et al: Acute hypotensive and renin-stimulating action of captopril before and during treatment with a beta blocking drug . Am J Cardiol 49:1564-1565, 1982 .

17.

MacGregor GA , Markandu ND , Banks RA , et al: Captopril in essential hypertension: contrasting effects and propranolol in essential hypertension Br Med J 284:693-696, 1982.

18.

Huang CM , Greco FD , Qunitanilla A. , et al: Comparison of antihypertensive effects of captopril and propranolol in essential hypertension. JAMA 245:478-482, 1981.

19.

Corea C. , Bertivolglio M. , Verdecchia I. : Low-dose captopril therapy in mild and moderate hypertension. Randomized comparison of twice daily vs three times daily doses. Hypertension 5 (Suppl III):157-159, 1983.

20.

Lederle RM : Captopril and hydrochlorothiazide in the fixed combination multicenter trial . J Cardiovasc Pharmacol 7 (Suppl 1):863-569, 1985.

21.

Sharpe DN : Comparison of captopril (SQ 14.225) with hydrochlorothiazide in the treatment of mild and severe essential hypertension. Med J Aust 66 Specl Suppl 2:24-26, 1979.

22.

Johnston CI , McGrath BP , Matthews PG : Comparison of the hormonal effects of captopril (SQ 14225) and hydrochlorothizide in the treatment of essential hypertension . Med J Aust 66 Specl Suppl 2:17-22, 1979.